スポンサーリンク

Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co., Ltd. | 論文

• Evaluation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtype Selectivity of a Variety of Anti-inflammatory Drugs Based on a Novel Assay for PPARδ(β)
• A New Aromatase Inhibitor, FR901537 II.Pharmacological and Antitumor Effects
• Large Scale Purification of Recombinant Insulin-Like Growth Factor I (IGF-I, Mecasermin) from a Fused Protein Produced in Escherichia coli
• An Approach to High-Level Production of Mecasermin (Somatomedin C) Fused Protein in Escherichia coli HB101
• Effects of a New Non : Steroidal 5α : Reductase Inhibitor, FK143, on the Prostate Gland in Beagle Dogs
• Effect of Recombinant Human Insulin-Like Growth Factor-I on Expression of Glucose Transporters, GLUT 2 and GLUT 4, in Streptozotocin-Diabetic Rat
• FR149175, a β_3-Adrenoceptor-Selective Agonist, Is a Possible Therapeutic Agent for Non-Insulin-Dependent Diabetes Mellitus
• Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
• Pharmacological Properties of FK886, a New, Centrally Active Neurokinin-1 Receptor Antagonist
• Antiemetic Effects of a Potent and Selective Neurokinin-1 Receptor Antagonist, FK886, on Cisplatin- and Apomorphine-Induced Emesis in Dogs

スポンサーリンク